Network

Claude Preudhomme

  • Université de Lille

External person

Julia Annabell Georgi

  • Technische Universität Dresden

External person

Robert K. Hills

  • University of Oxford
  • University of Birmingham
  • H. Lee Moffitt Cancer Center and Research Institute

External person

Christian Thiede

  • Technische Universität Dresden
  • AgenDix GmbH
  • Dept Med Microbiol

External person

Jan Braess

  • Hospital Barmherzige Brüder

External person

Christoph Röllig

  • Technische Universität Dresden

External person

Utz Krug

  • Medizinische Klinik III

External person

Catharina H.M.J. van Elssen

  • Maastricht University Medical Center
  • Netherlands Cancer Institute

External person

Carsten Müller-Tidow

  • Heidelberg University 
  • University Hospital Heidelberg
  • University of Münster
  • Martin Luther University Halle-Wittenberg

External person

Nicolas Duployez

  • Université de Lille

External person

Amanda Gilkes

  • Cardiff University

External person

Hubert Serve

  • University Hospital
  • University Hospital Frankfurt am Main

External person

Gert J. Ossenkoppele

  • Vrije Universiteit Amsterdam
  • University of Amsterdam
  • Amsterdam UMC
  • VU University Medical Center
  • Imaging and Biomarkers
  • Dept Hematol

External person

Annika Dufour

  • Klinikum der Universität München

External person

Laurene Fenwarth

  • Université de Lille
  • UMR9020-U1277 - CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies

External person

Rosemary Gale

  • University College London

External person

Nigel Russell

  • Nottingham University Hospitals NHS Trust
  • Guy's and St Thomas' NHS Foundation Trust

External person

Sarah Koch

  • Munich Leukemia Laboratory
  • Barcelona Institute for Global Health (ISGlobal)
  • Pompeu Fabra University
  • Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP)

External person

Charles Craddock

  • University Hospitals Birmingham NHS Foundation Trust
  • Queen Elizabeth University Hospital (Birmingham)
  • University of Birmingham
  • Birmingham Centre for Cellular Therapy and Transplantation
  • University of Warwick

External person

Hervé Dombret

  • Université Paris Cité
  • Hospital St. Louis

External person

H Berna Beverloo

  • Erasmus University Rotterdam

External person

Claire Schwab

  • Newcastle University
  • University of Newcastle, UK)

External person

Marie-Christiane Vekemans

  • Université catholique de Louvain

External person

Rachel Moore

  • University of Oxford

External person

Roxanne E. Cromwell

  • Erasmus University Rotterdam

External person

Bernhard J. Woermann

  • German Society of Hematology and Oncology

External person

Gerhard Ehninger

  • GEMoaB Monoclonals GmbH
  • AvenCell Europe GmbH

External person

Claudia D. Baldus

  • Universitätsklinikum Schleswig-Holstein
  • Kiel University
  • German Research Foundation

External person

Niels Asger Jakobsen

  • University of Oxford

External person

Martin Bornhäuser

  • Technische Universität Dresden
  • National Center for Tumour Diseases (NCT)

External person

Sylvie D. Freeman

  • University of Birmingham
  • NIHR Biomedical Research Centres

External person

Wolfgang E. Berdel

  • University Hospital Münster

External person

Lidwine W Tick

  • Netherlands Cancer Institute

External person

Jonathan A. Cook

  • University of Oxford

External person

Cecile Pautas

  • Hôpital Henri Mondor

External person

Kyra G. Compagne

  • Erasmus University Rotterdam

External person

Klaus Metzeler

  • University Hospital Leipzig

External person

Wolfgang Hiddemann

  • Klinikum der Universität München

External person

Torsten Haferlach

  • Munich Leukemia Laboratory
  • Munich Leukemia Laboratory (MLL)

External person

Ian Thomas

  • Cardiff University

External person

Sebastian Stasik

  • Technische Universität Dresden

External person

Manja Meggendorfer

  • Munich Leukemia Laboratory

External person

Tobias Herold

  • Klinikum der Universität München
  • German Research Center for Environmental Health

External person

Okke de Weerdt

  • St. Antonius Ziekenhuis

External person

Michael Kramer

  • Technische Universität Dresden
  • AvenCell Europe GmbH

External person

Markus G Manz

  • University Hospital Zürich
  • Swiss Group for Clinical Cancer Research
  • University of Zurich

External person

David Linch

  • University College London

External person

Paresh Vyas

  • Oxford University Hospitals NHS Foundation Trust
  • University of Oxford

External person

Jan Moritz Middeke

  • Technische Universität Dresden

External person

Otto Visser

MD, PhD

  • Isala Clinics
  • Netherlands Comprehensive Cancer Organization (IKNL)

External person

Christine J. Harrison

  • Newcastle University
  • University of Newcastle, UK)

External person

Mike Dennis

  • The Christie NHS Foundation Trust

External person

Claudia Haferlach

  • Munich Leukemia Laboratory

External person

Franziska Taube

  • Technische Universität Dresden

External person

Karsten Spiekermann

  • Klinikum der Universität München

External person

Alison Kennedy

  • University of Oxford

External person

Steven Knapper

  • Cardiff University

External person

Marlen Metzner

  • University of Oxford

External person

Maja Rothenberg-Thurley

  • Klinikum der Universität München

External person

Abin Thomas

  • Cardiff University

External person

Bart J Biemond

  • Vrije Universiteit Amsterdam

External person

Alan Burnett

  • Cardiff University

External person

Uwe Platzbecker

  • University Hospital Leipzig
  • Medical Clinic and Policinic 1

External person

Ariel Wang

  • University of Oxford

External person